We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.86M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.7M
3
CNR
Core Natural Resources Inc
CNR
+$8.26M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.63M
5
ORCL icon
Oracle
ORCL
+$6.25M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$14M
2
HTLF
Heartland Financial USA, Inc.
HTLF
+$11.1M
3
NVDA icon
NVIDIA
NVDA
+$9.36M
4
AMZN icon
Amazon
AMZN
+$8.75M
5
NFLX icon
Netflix
NFLX
+$8.58M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHM icon
1451
Pultegroup
PHM
$24.8B
– –
-2,735
Closed -$298K
PLRX icon
1452
Pliant Therapeutics
PLRX
$64.4M
– –
-30,782
Closed -$405K
PM icon
1453
Philip Morris
PM
$290B
– –
-3,306
Closed -$398K
PLXS icon
1454
Plexus
PLXS
$7.16B
– –
-1,647
Closed -$258K
PMVP icon
1455
PMV Pharmaceuticals
PMVP
$65.6M
– –
-28,700
Closed -$43.3K
PNW icon
1456
Pinnacle West Capital
PNW
$12B
– –
-2,724
Closed -$231K
PR
1457
Permian Resources
PR
$17.8B
– –
-25,597
Closed -$368K
PRGO icon
1458
Perrigo
PRGO
$1.75B
– –
-10,053
Closed -$258K
PRU icon
1459
CALL
Prudential Financial
PRU
$42.1B
– –
-2,600
Closed -$308K
PRU icon
1460
PUT
Prudential Financial
PRU
$42.1B
– –
-2,600
Closed -$308K
PTC icon
1461
PTC
PTC
$16.4B
– –
-2,179
Closed -$401K
PTEN icon
1462
Patterson-UTI
PTEN
$4.19B
– –
-18,300
Closed -$151K
PTLO icon
1463
Portillo's
PTLO
$325M
– –
-16,257
Closed -$153K
QCOM icon
1464
CALL
Qualcomm
QCOM
$170B
– –
-1,400
Closed -$215K
QCOM icon
1465
PUT
Qualcomm
QCOM
$170B
– –
-1,400
Closed -$215K
RARE icon
1466
Ultragenyx Pharmaceutical
RARE
$2.64B
– –
-5,822
Closed -$245K
RCKT icon
1467
Rocket Pharmaceuticals
RCKT
$397M
– –
-47,247
Closed -$594K
REAL icon
1468
The RealReal
REAL
$1.45B
– –
-10,463
Closed -$114K
REXR icon
1469
Rexford Industrial Realty
REXR
$8.13B
– –
-15,546
Closed -$601K
RIOT icon
1470
Riot Platforms
RIOT
$7.34B
– –
-18,439
Closed -$188K
RITM icon
1471
Rithm Capital
RITM
$5.65B
– –
-19,730
Closed -$214K
RIVN icon
1472
Rivian
RIVN
$23.7B
– –
-11,527
Closed -$153K
RMNI icon
1473
Rimini Street
RMNI
$458M
– –
-11,512
Closed -$30.7K
ROL icon
1474
Rollins
ROL
$17.9B
– –
-10,213
Closed -$473K
RRX icon
1475
Regal Rexnord
RRX
$11.5B
– –
-48,241
Closed -$7.48M
57 58
59
60 61

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.